Remove Science Remove Structure Based Drug Design (SBDD) Remove Treatment
article thumbnail

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

Structure-based design approach has identified potent compounds for further development as oral treatments for SARS-CoV-2 infection and related human coronaviruses. Zhang, et al, Science (2020) DOI: 10.1126/science.abb3405. TOKYO and CAMBRIDGE, England , Nov. References. Hilgenfeld, Febs J.